The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr11
start 1995176
end 2001470
lncRNA name H19
entrez id 283120
hgnc id HGNC:4713
ensg id ENSG00000130600
refseq id NR_002196
methods qPCR, RNAi, Western blot, Northern blot, ChIP etc.
regulated up-regulated
function description We show here that H19 transcription is up-regulated during the S-phase of growth-stimulated cells and that the H19 promoter is activated by E2F1 in breast cancer cells. H19 repression by pRb and E2F6 confirms the E2F1-dependent control of the H19 promoter. Consistently, we demonstrate by chromatin immunoprecipitation assays that endogenous E2F1 is recruited to the H19 promoter in vivo. The functionality of E2F promoter sites was further confirmed by gel shift and mutagenesis experiments, revealing that these sites are required for binding and promoter response to E2F1 exogenous expression and serum stimulation.
pubmed id 15985428
year 2005
title H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1.
drug X
circulating X
survival X

CopyRight © University of Miami, USA; Harbin Medical University, China